Pharma shares in focus; Aurobindo Pharma hits new high
JB Chemicals, Alembic Pharma, Aurobindo Pharma, Ipca Laboratories and Dishman Pharma were up 3%-11% each.
)
Shares of pharmaceutical companies were in focus and trading higher by up to 10% each on the Bombay Stock Exchange (BSE).
JB Chemicals & Pharmaceuticals (up 11% at Rs 252), Alembic Pharmaceuticals (5.5% at Rs 688), Aurobindo Pharma (3% at Rs 1,436), Ipca Laboratories (3% at Rs 698) and Dishman Pharmaceuticals (3% at Rs 158) were up 3%-10% each. Lupin, Sun Pharmaceutical Industries, Ajanta Pharma, Cadila Healthcare, Wockhardt and Unichem Laboratories were up 1%-2% each on the BSE.
At 1024 hours, S&P BSE Healthcare index, the largest gainer among sectoral indices, was up 1% or 162 points at 16,424, after hitting a high of 16,477 in intra-day trades. The S&P BSE Sensex was up 0.24% at 27,871.
Aurobindo Pharma was up 3% at Rs 1,432, after hitting a new high of Rs 1,444 in early morning trades on the BSE.
In the past seven trading sessions, the stock rallied 13% from Rs 1,277 on June 15, after the company received the final approval from the US Food & Drug Administration (US FDA) to manufacture and market extended Phenytoin sodium capsules, an anti-epileptic drug for controlling seizures.
On June 22, the company had received final approval from the USFDA to manufacture and market Entacapone tablets and Azithromycin injections.
Entacapone, a generic version of Comtan tablets of Orion Corporation, is used in the treatment of Parkingons's disease. Azithromycin is a generic version of Zitromax of Pfizer and is indicated for treatment of patients with infections including pneumonia.
JB Chemicals & Pharmaceuticals (up 11% at Rs 252), Alembic Pharmaceuticals (5.5% at Rs 688), Aurobindo Pharma (3% at Rs 1,436), Ipca Laboratories (3% at Rs 698) and Dishman Pharmaceuticals (3% at Rs 158) were up 3%-10% each. Lupin, Sun Pharmaceutical Industries, Ajanta Pharma, Cadila Healthcare, Wockhardt and Unichem Laboratories were up 1%-2% each on the BSE.
At 1024 hours, S&P BSE Healthcare index, the largest gainer among sectoral indices, was up 1% or 162 points at 16,424, after hitting a high of 16,477 in intra-day trades. The S&P BSE Sensex was up 0.24% at 27,871.
Aurobindo Pharma was up 3% at Rs 1,432, after hitting a new high of Rs 1,444 in early morning trades on the BSE.
In the past seven trading sessions, the stock rallied 13% from Rs 1,277 on June 15, after the company received the final approval from the US Food & Drug Administration (US FDA) to manufacture and market extended Phenytoin sodium capsules, an anti-epileptic drug for controlling seizures.
On June 22, the company had received final approval from the USFDA to manufacture and market Entacapone tablets and Azithromycin injections.
Entacapone, a generic version of Comtan tablets of Orion Corporation, is used in the treatment of Parkingons's disease. Azithromycin is a generic version of Zitromax of Pfizer and is indicated for treatment of patients with infections including pneumonia.
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jun 24 2015 | 10:36 AM IST